# LOPINAVIR AND RITONAVIR
> **ANDA214696** · Abbreviated New Drug Application (Generic) · Sponsor: MICRO LABS · Approved 2025-12-11
## Drug
- **FDA Application Number:** ANDA214696
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LOPINAVIR AND RITONAVIR
- **Generic name:** Lopinavir
- **Active ingredients:** LOPINAVIR; RITONAVIR
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MICRO LABS
- **First approval:** 2025-12-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214696)
---
*AI Analytics · CC0 1.0*